Drug-Related Problems : Focus on Age and Diabetes

Completed

• Conditions: Adverse Drug Events
• Interventions: Other: Detection of Adverse Drug Events or Drug-Related Problems

• Registration Number: NCT04692220
• Lead Sponsor: University Hospital, Montpellier

Brief Summary

Drug-Related Problems (DRP) are a variety of events or circumstances that can interfere with the expected results of a treatment. They may be due to the drug itself, its association with other treatments, its incompatibility with the patient, its misuse... When these situations result in harm, they are referred to as adverse drug events (ADEs). DRP and particularly ADE represent a major public health problem in healthcare institutions because of their impact on morbidity and health costs.

DRPs are largely preventable and actions can be set up to detect and correct them. It is in this context that clinical pharmacy has expanded, with the development of new activities to help secure drug management. In our institution, the investigators have implemented several activities in different care services, including

* medication reconciliation,

* an ADE detection. These activities have interesting and encouraging results in terms of impact on the prevention of DRP. However, they can only be carried out on a limited number of patients, depending on the pharmaceutical resources available. The investigators therefore need tools to prioritize our activities on the most at-risk patients.

In this study, the investigators seek to identify DRP risk factors and develop DRP risk scores, with the objective to improve the detection and even prevention of DRP.

Translated with www.DeepL.com/Translator (free version)

Detailed Description

Not available

Study Timeline

• Study Start: 2011-11-01
• Study First Submitted: 2020-12-28
• Study First Submitted QC: 2020-12-28
• Study First Posted: 2020-12-31
• Primary Completion: 2021-03-01
• Study Completion: 2021-03-30
• Status Verified: 2021-10
• Last Update Submitted: 2021-10-22
• Last Update Posted: 2021-10-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 27000

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Patients with an Adverse Drug Events or Drug-Related Problems	Detection of Adverse Drug Events or Drug-Related Problems	Patients with an Adverse Drug Events or Drug-Related Problems
Patients without an Adverse Drug Events or Drug-Related Problems	Detection of Adverse Drug Events or Drug-Related Problems	Patients without an Adverse Drug Events or Drug-Related Problems

Primary Outcome Measures

Name	Time	Method
Variables associated with the presence of an Adverse Drug Events or Drug-Related Problems	1 day	Variables associated with the presence of an Adverse Drug Events or Drug-Related Problems

Secondary Outcome Measures

Name	Time	Method
Number and type of Adverse Drug Events and Drug-Related Problems	1 day	Number and type of Adverse Drug Events and Drug-Related Problems

Trial Locations

Locations (1)

Uhmontpellier; 🇫🇷 Montpellier, France